|
|
Other links at Articles > Hematology-Oncology |
| 1. |
Dose-Dense Paclitaxel and Carboplatin in Ovarian Cancer
|
|
|
A weekly regimen provided longer progression-free survival and overall survival than standard treatment in patients with ovarian cancer. Dr. Maurie Markman summarizes the Sept. 20 Lancet article. Medscape Hematology-Oncology
|
|
|